The US government already was subsidizing the cost: https://www.nei.nih.gov/research-and-training/research-news/lucentis-effective-proliferative-diabetic-retino

The US government already was subsidizing the cost: https://www.nei.nih.gov/research-and-training/research-news/lucentis-effective-proliferative-diabetic-retinopathy https://www.nei.nih.gov/research-and-training/research-news/... It subsidizing the cost of developing many drugs. The question is whether their pricing reflects that.